Corporate Development

Institutional Partnering & Licensing

Advanced Technologies for Novel Therapeutics engages in strategic co-development partnerships and regional licensing transactions for our targeted oncology candidates. We offer biopharmaceutical partners and institutional life science investors direct access to primary empirical datasets, structural chemistry modeling, and validated clinical pipeline milestones.

Direct Channel

Corporate Inquiries

Our executive leadership team directly reviews confidential submissions from institutional life science investors, pharmaceutical licensing managers, and clinical research institutions. Please specify your organizational affiliation, research scope, and proposed collaboration parameters to ensure rapid routing to the appropriate team member.

Secure Data Room Access

Accredited institutional investors and prospective biopharmaceutical partners conducting formal technical due diligence may request secure credentialed access to our confidential data repository, proprietary structural chemistry dossiers, and complete patent estate documentation.